Profound MedicalPROF
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Profound MedicalPROF
0
0
(0%)
財務數據
損益表
- 0.02
- 0.03
- 0.04
- 0.03
- 0.02
- 0.05
- 0.06
- 0.05
- 0.02
- 0.10
- 55.18
- 26.82
- 30.83
- -29.26
- -15.64
- 139.21
- 13.01
- -10.71
- -53.48
- 295.89
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q3 | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | |
營業收入淨額 | 9,830 | 2,483 | 5,337 | 5,977 | 5,289 | 2,211 | 2,621 | 3,705 | 2,832 | 2,233 |
營業成本 | 2,150 | 536 | 1,505 | 1,986 | 1,358 | 593 | 768 | 1,181 | 1,044 | 812 |
營業毛利 | 7,680 | 1,947 | 3,832 | 3,991 | 3,931 | 1,618 | 1,853 | 2,524 | 1,788 | 1,421 |
營業費用 | 15,501 | 13,013 | 11,853 | 11,360 | 12,844 | 15,424 | 13,019 | 11,283 | 10,786 | 9,263 |
研發費用 | 5,806 | 5,654 | 5,262 | 4,272 | 5,418 | 6,098 | 4,808 | 4,685 | 4,166 | 4,205 |
推銷及管理費用 | 9,695 | 7,359 | 6,591 | 7,088 | 7,426 | 9,326 | 8,211 | 6,598 | 6,620 | 5,058 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -7,821 | -11,066 | -8,021 | -7,369 | -8,913 | -13,806 | -11,166 | -8,759 | -8,998 | -7,842 |
其他收入及費用 | 808 | 1,245 | 616 | -1,850 | 936 | -2,168 | 38 | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | 199 | - |
稅前純益 | -7,726 | -9,485 | -7,028 | -8,149 | -7,855 | -15,631 | -10,683 | -5,572 | -9,188 | -6,900 |
所得稅 | -4 | 55 | 25 | 26 | 121 | 64 | 41 | -238 | 177 | 19 |
稅後純益 | -7,722 | -9,540 | -7,053 | -8,175 | -7,976 | -15,695 | -10,724 | -5,334 | -9,365 | -6,919 |
基本每股稅後盈餘(元) | -0.21 | -0.26 | -0.19 | -0.27 | -0.26 | -0.52 | -0.36 | -0.20 | -0.38 | -0.28 |
稀釋每股稅後盈餘(元) | -0.21 | -0.27 | -0.19 | -0.27 | -0.26 | -0.52 | -0.36 | -0.20 | -0.38 | -0.28 |
基本平均股數(千股) | 36556.00 | 36350.00 | 36297.00 | 30726.00 | 30104.00 | 30053.00 | 30041.00 | 25770.00 | 24534.00 | 24440.00 |
稀釋平均股數(千股) | 36556.00 | 36350.00 | 36297.00 | 30726.00 | 30104.00 | 30053.00 | 30041.00 | 25770.00 | 24534.00 | 24440.00 |
還原基本每股稅後盈餘(元) | -0.21 | -0.26 | -0.19 | -0.27 | -0.26 | -0.52 | -0.36 | -0.20 | -0.38 | -0.28 |
還原稀釋每股稅後盈餘(元) | -0.21 | -0.27 | -0.19 | -0.27 | -0.26 | -0.52 | -0.36 | -0.20 | -0.38 | -0.28 |
還原基本平均股數(千股) | 36,556 | 36,350 | 36,297 | 30,726 | 30,104 | 30,053 | 30,041 | 25,770 | 24,534 | 24,440 |
還原稀釋平均股數(千股) | 36,556 | 36,350 | 36,297 | 30,726 | 30,104 | 30,053 | 30,041 | 25,770 | 24,534 | 24,440 |
EBITDA(千元) | -7,590 | -9,346 | -6,923 | -8,035 | -7,701 | -15,487 | -10,472 | -5,496 | -8,775 | -6,666 |